AMGEN INC is 131.4x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($183.41 B vs $1.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GLUE | AMGN |
|---|---|---|
| Market cap | $1.40 B | $183.41 B |
| US-listed rank | #2377 | #79 |
| Revenue (latest FY) | - | $36.75B |
| Net income (latest FY) | -$38.60M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 352 | 1,011 |
AMGEN INC is 131.4x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($183.41 B vs $1.40 B).
Full pages: Monte Rosa Therapeutics, Inc. and AMGEN INC, or browse the full rankings.